? We are proposing to develop an International Core within the UNC CFAR (Core I), designed to support? research, training, technology transfer and broad ethical considerations at sites in four countries which have? been extensively involved with the UNC CFAR for many years: Malawi, Democratic Republic of the Congo? (DRC), South Africa and the Peoples Republic of China. The addition of an International Core is an? essential amplification of ongoing activities. Specific technical assistance/capacity building services, to be? coordinated with other CFAR Cores, include assistance with: laboratory infrastructure; clinical database? development; data analysis for article publication; grant writing, including intensive one-on-one tutorials for? young investigators in CFAR collaborations; coordinating IRB approvals, consent form writing, navigating? NIH regulations, and responding to questions about human subjects protections; and planning and? coordinating international workshops.? Core I will enhance coordination of information about ongoing international collaborations and the? availability of training programs, and work to develop new collaborations/through the following services:? maintain interactive information database about CFAR international research; assist UNC Fogarty AITRP? and other training programs to identify international scholars for potential training; and assist community? advisory boards in key collaborating countries to identify topics critical to the local community, and to? disseminate research results through yearly in-country meetings.? By directing world attention to underlying social and economic inequalities, the AIDS epidemic has also? re-defined important aspects of the ethical conduct of research. For this reason, it is doubly important for the? CFAR to address the moral as well as practical challenges that are often raised in international HIV/AIDS? research. Bringing together resources at UNC and the CFAR partners, FHI and RTI, Core I will develop the? CFAR Ethics Resource Service, with the following objectives: ensure that broader ethical issues are part of? the ongoing discussion of international HIV/AIDS research, including offering training activities for UNC? researchers; disseminate information, experience, and expertise in ethics so that CFAR researchers are? aware of current conceptualizations and recommendations in these domains; respond to ethics and IRB? questions from CFAR researchers and collaborators; assess ethics capacity building activities as defined by? our collaborating researchers and institutions in Malawi, the DRC, South Africa, and China; and further? develop and support an International Ethics Working Group which will foster both research and training? activities at UNC and in partner countries.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-11
Application #
7644970
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-06-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
11
Fiscal Year
2008
Total Cost
$224,696
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Evon, Donna M; Stewart, Paul W; Amador, Jipcy et al. (2018) A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One 13:e0196908
Gausi, Blessings; Chagomerana, Maganizo B; Tang, Jennifer H et al. (2018) Human Immunodeficiency Virus Serodiscordance and Dual Contraceptive Method Use Among Human Immunodeficiency Virus-infected Men and Women in Lilongwe, Malawi. Sex Transm Dis 45:747-753
Kalayjian, Robert C; Albert, Jeffrey M; Cremers, Serge et al. (2018) Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy. AIDS 32:2517-2524
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Cheng, Weibin; Xu, Huifang; Zhong, Fei et al. (2018) Can HIV service data be used for surveillance purposes?: a case study in Guangzhou, China. BMC Public Health 18:1268
Gradissimo, Ana; Lam, Jessica; Attonito, John D et al. (2018) Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women. Cancer Epidemiol Biomarkers Prev 27:1407-1415
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Price, Joan T; Mollan, Katie R; Fuseini, Nurain M et al. (2018) Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol. Pilot Feasibility Stud 4:21
Davy-Mendez, Thibaut; Napravnik, Sonia; Zakharova, Oksana et al. (2018) Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr 79:510-518
Cole, Stephen R; Edwards, Jessie K; Westreich, Daniel et al. (2018) Estimating multiple time-fixed treatment effects using a semi-Bayes semiparametric marginal structural Cox proportional hazards regression model. Biom J 60:100-114

Showing the most recent 10 out of 1688 publications